“I expect that member states ratify the Recovery Plan in time because it is in their interest to do so so that the Commission can go to the markets to collect the money,” Ursula von der Leyen told daily la Repubblica in an interview.
Von der Leyen added that Astrazeneca (LON:AZN) would provide 40 million doses of anti-COVID vaccines in Europe in the coming two months and “we expect it will make up for cuts seen in first quarter”.
She also confirmed the target to vaccinate 70% of Europe’s adult population by the summer, adding that 300 million doses of Pfizer (NYSE:PFE), Moderna (NASDAQ:MRNA) and Astrazeneca vaccines were coming in the second quarter and, if approved, further 80 million vials from Johnson&Johnson and Curevac.
Source: Economy - investing.com
